How the Kodak generic-drug ingredients deal developed, and why it fell apart: a snapshot

Peter Navarro called the Kodak project a ‘great win for the American people’ in late July, but two weeks later he was characterizing executives at the legendary company as having made ‘probably the dumbest decisions made by executives in corporate history.’